A new intramuscular (IM) injection option of Biogen’s Plegridy (peginterferon beta-1a) has been approved by the European Commission for the treatment of relapsing-remitting multiple sclerosis (MS).
Part 1 of this two-part series on injection techniques describes the evidence base and procedure for administering an intramuscular injection. This updates an article previously published in 2018.
In a recent study published in the journal PNAS, researchers demonstrated higher comparative efficacy of the intranasal (IN) route of coronavirus disease 2019 (COVID-19) vaccine administration versus ...
Routes of drug administration refer to the right path or the required route through which a drug has to be administered into the body to obtain maximum benefit. A drug administered into the body ...
Early termination of prolonged seizures with intravenous administration of benzodiazepines improves outcomes. For faster and more reliable administration, paramedics increasingly use an intramuscular ...
In patients on hemodialysis with a history of failure to respond to hepatitis B vaccination, intradermal revaccination is more effective than repeat intramuscular vaccination. Intradermal vaccine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results